Skip to main content

Vivitrol Enhances The Treatment for Heroin and Opiod Addiction

The U.S.D.A recently approved the drug Vivitrol for the treatment of opioid  and heroin addiction. Vivitrol is an extended release formulation of naltrexone, an opioid receptor antagonist. Clinical trials have shown Vivitrol to be effective in preventing not only relapse to drug use following detoxification, but also to diminish cravings that often drive it. The National Institute on Drug Abuse (NIDA)  reported that heroin addiction afflicts an estimated 810,000 people in this country. NIDA's website states that in 2008, 1.85 million people in the U.S. met the diagnostic criteria for abuse or dependence on opioid pain relievers, such as Oxycontin and Vicodin.

Popular posts from this blog

PHOTOS: MMC Through the Years

Mobile Medical Corporation (MMC) is excited to be celebrating our 30th Anniversary in 2020! MMC was founded on June 21, 1990. Check out some photos as we have grown over the years!            

Synthetic Marijuana Making Local and National Headlines

Synthetic Marijuana, also known as "K-2" or "Spice" is a mixture of common herbs sprayed with synthetic chemicals that mirror the high of Marijuana. The synthetic product is sold as incense in head shops, tobacco stores and convenient stores. So far, twelve states have banned the sale of Synthetic Marijuana - (Kansas, Georgia, Alabama, Tennessee, Missouri, Louisiana, Mississippi, Arkansas, Oregon, Illinois, Michigan, and Kentucky). The American Association of Poison Control Centers reported that within the past year there have been over 500 cases of negative reactions to the still legal yet dangerous drug. On the national level the U.S. Drug Enforcement Administration (DEA) recently designated certain chemicals that are present within Synthetic Marijuana to the same category that heroin and LSD are part of and further emphasizes the need to be able to test blood and urine for Synthetic Marijuana use. On the local level- The Herald Online reported that Fort Mill,...

Random Drug Testing Benefits Employers

Drug testing programs aim to prevent the hiring of drug-using applicants while deterring drug use among current employees. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), 21.4 percent of employed adults used illicit drugs within the past month. Results from the 2014 Quest Diagnostics Drug Testing Index™ (DTI) show that, in the general U.S. workforce, random urine drug test positivity rates are higher (5.7 percent) than they are for pre-employment (4.0 percent) or periodic (1.6 percent). Random or “spot” drug testing works as a drug use deterrent because these programs are conducted in an unannounced and unpredictable manner. Utilizing a random drug testing program may help employers by: Deterring current employees from engaging in drug use Preventing the need for substance abuse recovery programs Helping reduce health insurance costs Improving attendance and employee productivity Providing a safer workplace with reduced accidents However, set...